U.S. markets closed
  • S&P 500

    4,008.01
    -15.88 (-0.39%)
     
  • Dow 30

    32,223.42
    +26.76 (+0.08%)
     
  • Nasdaq

    11,662.79
    -142.21 (-1.20%)
     
  • Russell 2000

    1,783.43
    -9.24 (-0.52%)
     
  • Crude Oil

    113.71
    -0.49 (-0.43%)
     
  • Gold

    1,824.20
    +10.20 (+0.56%)
     
  • Silver

    21.64
    +0.09 (+0.41%)
     
  • EUR/USD

    1.0440
    +0.0023 (+0.22%)
     
  • 10-Yr Bond

    2.8770
    -0.0580 (-1.98%)
     
  • GBP/USD

    1.2328
    +0.0065 (+0.53%)
     
  • USD/JPY

    128.9790
    -0.2060 (-0.16%)
     
  • BTC-USD

    30,105.67
    -1,123.97 (-3.60%)
     
  • CMC Crypto 200

    667.04
    +424.36 (+174.87%)
     
  • FTSE 100

    7,464.80
    +46.65 (+0.63%)
     
  • Nikkei 225

    26,547.05
    +119.40 (+0.45%)
     

Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week

·2 min read
Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Through Thursday's closing bell, Bristol Myers Squibb (NYSE: BMY) shares have tracked higher by a respectable 8.2%, Pfizer (NYSE: PFE) stock is up by an eye-popping 17.5%, and Eli Lilly (NYSE: LLY) has seen its equity rise by a healthy 14.6%, according to data from S&P Global Market Intelligence. As a result, Pfizer and Lilly's shares are both trading close to their 52-week highs right now, while Bristol's stock has regained a fair amount of lost ground after trending lower for most of 2021.